{"id":"estradiol-vaginal-cream","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal irritation or burning"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Vaginal bleeding or spotting"}]},"_chembl":null,"_dailymed":{"setId":"c895ac14-5dbd-4201-bf3e-ba7c38a4e994","title":"ESTRADIOL VAGINAL CREAM (ESTRADIOL) CREAM [PRASCO LABORATORIES]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Estradiol is a potent estrogen that binds to estrogen receptors in vaginal epithelial and supporting tissues, promoting cell proliferation, increasing blood flow, and restoring vaginal moisture and elasticity. The vaginal route of administration allows for high local concentrations while minimizing systemic absorption, reducing the risk of systemic hormone exposure compared to oral hormone replacement therapy.","oneSentence":"Estradiol vaginal cream delivers the hormone estradiol directly to vaginal tissues to restore local estrogen levels and relieve menopausal vaginal symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:29:43.637Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrophic vaginitis and vaginal atrophy associated with menopause"},{"name":"Vaginal dryness and dyspareunia in postmenopausal women"}]},"trialDetails":[{"nctId":"NCT03844412","phase":"PHASE2","title":"Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments","status":"COMPLETED","sponsor":"Duke University","startDate":"2019-11-04","conditions":"Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome","enrollment":209},{"nctId":"NCT05672901","phase":"NA","title":"Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause","status":"RECRUITING","sponsor":"Stratpharma AG","startDate":"2023-04-04","conditions":"Genitourinary Syndrome of Menopause","enrollment":100},{"nctId":"NCT05317364","phase":"PHASE4","title":"Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2022-07-14","conditions":"Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence","enrollment":38},{"nctId":"NCT06353269","phase":"PHASE4","title":"Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-06-14","conditions":"Recurrent Urinary Tract Infection, Hypoestrogenism","enrollment":111},{"nctId":"NCT06873971","phase":"NA","title":"Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause","status":"RECRUITING","sponsor":"University of Nove de Julho","startDate":"2025-12-10","conditions":"Genitourinary Syndrome of Menopause","enrollment":60},{"nctId":"NCT03640624","phase":"NA","title":"Multidisciplinary Treatment of Chronic Vulvar Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2018-09-18","conditions":"Vulvodynia, Chronic Pain","enrollment":106},{"nctId":"NCT07260825","phase":"PHASE2, PHASE3","title":"Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"TriHealth Inc.","startDate":"2025-12","conditions":"Vulvodynia, Dyspareunia, Lichen Sclerosus of Vulva","enrollment":44},{"nctId":"NCT05723601","phase":"PHASE4","title":"Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-01-12","conditions":"Recurrent Urinary Tract Infection","enrollment":21},{"nctId":"NCT01886794","phase":"PHASE4","title":"Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2013-06-06","conditions":"Pelvic Floor Disorders","enrollment":7},{"nctId":"NCT05472779","phase":"PHASE2","title":"Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections","status":"COMPLETED","sponsor":"Stephanie Wang Zuo","startDate":"2023-01-03","conditions":"Recurrent Urinary Tract Infection","enrollment":114},{"nctId":"NCT06969326","phase":"PHASE3","title":"Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-05-01","conditions":"Postoperative Bleeding, Gender Dysphoria, Hysterectomy","enrollment":48},{"nctId":"NCT06197295","phase":"PHASE4","title":"Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-16","conditions":"Urinary Bladder, Overactive, Effect of Drug","enrollment":200},{"nctId":"NCT06479720","phase":"PHASE4","title":"Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-16","conditions":"Effect of Drug, Urinary Bladder, Overactive","enrollment":300},{"nctId":"NCT02218463","phase":"NA","title":"Treatment of Prepubertal Labial Adhesions","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2014-09","conditions":"Prepubertal Labial Adhesions","enrollment":43},{"nctId":"NCT03116022","phase":"PHASE1","title":"Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-06-01","conditions":"Dyspareunia, Menopause, Sexual Dysfunction","enrollment":125},{"nctId":"NCT05221021","phase":"PHASE4","title":"Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome","status":"RECRUITING","sponsor":"Walter Reed National Military Medical Center","startDate":"2022-10-01","conditions":"Overactive Bladder Syndrome","enrollment":152},{"nctId":"NCT03332303","phase":"PHASE3","title":"Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy","status":"COMPLETED","sponsor":"Prasco LLC","startDate":"2017-10-26","conditions":"Vulvar and Vaginal Atrophy","enrollment":540},{"nctId":"NCT04301934","phase":"NA","title":"Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-06-01","conditions":"Urinary Tract Infections","enrollment":12},{"nctId":"NCT05478746","phase":"NA","title":"Effects of Flourish HEC on Localized Provoked Vulvodynia","status":"COMPLETED","sponsor":"Vaginal Biome Science","startDate":"2022-09-26","conditions":"Vulvodynia, Vestibulodynia, Vulvar Diseases","enrollment":7},{"nctId":"NCT04544475","phase":"NA","title":"A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2021-09-01","conditions":"Genitourinary Syndrome of Menopause (GSM)","enrollment":49},{"nctId":"NCT05458375","phase":"EARLY_PHASE1","title":"Vaginal Estradiol Use in Pessary Care","status":"TERMINATED","sponsor":"University of South Florida","startDate":"2022-12-29","conditions":"Pelvic Organ Prolapse, Urinary Incontinence, Pessary Ulcer of Vagina","enrollment":11},{"nctId":"NCT05783479","phase":"NA","title":"Pharmacological Preparation of the Cervix for Hysteroscopy","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2022-06-01","conditions":"Uterine Polyp, Uterine Bleeding, Endometrium; Senility","enrollment":96},{"nctId":"NCT01816139","phase":"PHASE3","title":"Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women","status":"COMPLETED","sponsor":"Warner Chilcott","startDate":"2013-01-31","conditions":"Vulvovaginal Atrophy","enrollment":576},{"nctId":"NCT01400776","phase":"PHASE3","title":"Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women","status":"COMPLETED","sponsor":"Warner Chilcott","startDate":"2011-06-29","conditions":"Postmenopausal Vulvovaginal Atrophy","enrollment":722},{"nctId":"NCT01455597","phase":"PHASE3","title":"Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)","status":"COMPLETED","sponsor":"Warner Chilcott","startDate":"2011-10-20","conditions":"Vulvovaginal Atrophy","enrollment":309},{"nctId":"NCT01845649","phase":"PHASE3","title":"Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia","status":"COMPLETED","sponsor":"Warner Chilcott","startDate":"2013-04-12","conditions":"Vulvovaginal Atrophy","enrollment":550},{"nctId":"NCT05306405","phase":"PHASE1, PHASE2","title":"Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-02-20","conditions":"Cervix; Pregnancy","enrollment":120},{"nctId":"NCT02195986","phase":"PHASE3","title":"A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2014-06","conditions":"Atrophic Vaginitis","enrollment":366},{"nctId":"NCT03493126","phase":"PHASE4","title":"Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2018-10-15","conditions":"Vaginal Atrophy","enrollment":59},{"nctId":"NCT02995694","phase":"PHASE3","title":"A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis","status":"COMPLETED","sponsor":"Alvogen Pine Brook LLC","startDate":"2016-03","conditions":"Atrophic Vaginitis","enrollment":535},{"nctId":"NCT02770365","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2016-05","conditions":"Atrophy","enrollment":695},{"nctId":"NCT02524769","phase":"NA","title":"The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides","status":"COMPLETED","sponsor":"Loyola University","startDate":"2015-12","conditions":"Overactive Bladder","enrollment":27},{"nctId":"NCT04232813","phase":"PHASE3","title":"Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream","status":"COMPLETED","sponsor":"Instituto Palacios","startDate":"2020-01-09","conditions":"Vulvovaginal Atrophy","enrollment":120},{"nctId":"NCT03385551","phase":"","title":"Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream","status":"COMPLETED","sponsor":"Instituto Palacios","startDate":"2019-12-09","conditions":"Vulvovaginal Atrophy","enrollment":120},{"nctId":"NCT03779633","phase":"PHASE4","title":"Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2017-02-02","conditions":"Pelvic Organ Prolapse","enrollment":120},{"nctId":"NCT01958073","phase":"PHASE4","title":"Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2013-10","conditions":"Recurrent Urinary Tract Infection","enrollment":35},{"nctId":"NCT02859285","phase":"NA","title":"A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women","status":"COMPLETED","sponsor":"ProHealth Care, Inc","startDate":"2016-04","conditions":"Hypoactive Sexual Desire Disorder","enrollment":30},{"nctId":"NCT03294538","phase":"PHASE3","title":"Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2016-05-18","conditions":"Atrophic Vaginitis","enrollment":663},{"nctId":"NCT02691936","phase":"NA","title":"Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-03","conditions":"Atrophic Vaginitis, Menopause","enrollment":69},{"nctId":"NCT03032848","phase":"PHASE4","title":"Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients","status":"COMPLETED","sponsor":"Universidade Federal do Paraná","startDate":"2013-11-26","conditions":"Vaginitis Atropic, Pelvic Organ Prolapse, Endometrial Hyperplasia","enrollment":69},{"nctId":"NCT00465894","phase":"NA","title":"Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-04","conditions":"Overactive Bladder","enrollment":58},{"nctId":"NCT02860897","phase":"PHASE4","title":"Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery","status":"WITHDRAWN","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2016-07","conditions":"Estrogen, Menopause, Pelvic Floor Disorders","enrollment":""},{"nctId":"NCT01613170","phase":"PHASE4","title":"Premarin Versus Toviaz for Treatment of Overactive Bladder","status":"UNKNOWN","sponsor":"The Cleveland Clinic","startDate":"2012-04","conditions":"Overactive Bladder","enrollment":90},{"nctId":"NCT02419729","phase":"PHASE3","title":"Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Faculdade de Medicina do ABC","startDate":"2015-03","conditions":"Vulvovaginal Atrophy","enrollment":45},{"nctId":"NCT02316249","phase":"PHASE2","title":"Vaginal Creams to Reduce Vaginal Erosion in Pessary Users","status":"WITHDRAWN","sponsor":"Northwell Health","startDate":"2015-04","conditions":"Atrophy of Vagina, Vaginal Ulceration, Vaginitis","enrollment":""},{"nctId":"NCT00803335","phase":"PHASE3","title":"The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse","status":"COMPLETED","sponsor":"TriHealth Inc.","startDate":"2008-12","conditions":"Pelvic Organ Prolapse, Vaginal Atrophy","enrollment":54},{"nctId":"NCT01813162","phase":"PHASE1","title":"In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-12","conditions":"HIV Prevention","enrollment":101},{"nctId":"NCT01810315","phase":"PHASE1","title":"Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-09","conditions":"HIV Prevention","enrollment":40},{"nctId":"NCT01319968","phase":"","title":"Postpartum Dyspareunia Resulting From Vaginal Atrophy","status":"COMPLETED","sponsor":"Meir Medical Center","startDate":"2011-03","conditions":"Vulvovaginal Atrophy, Dyspareunia Among Puerperal Women","enrollment":117},{"nctId":"NCT01778985","phase":"PHASE4","title":"Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2012-12","conditions":"Pelvic Organ Prolapse, Menopause","enrollment":30},{"nctId":"NCT00698035","phase":"PHASE2","title":"Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2007-03","conditions":"Sexual Dysfunction, Physiological","enrollment":76},{"nctId":"NCT00908570","phase":"PHASE1","title":"Topical Estriol for Vaginal Health","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2009-06","conditions":"Vaginal Health","enrollment":104},{"nctId":"NCT00484107","phase":"","title":"Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-09","conditions":"Postmenopause","enrollment":200},{"nctId":"NCT00167921","phase":"PHASE1","title":"Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-10","conditions":"Atrophic Vaginitis","enrollment":24}],"_emaApprovals":[],"_faersSignals":[{"count":83,"reaction":"OFF LABEL USE"},{"count":72,"reaction":"PRODUCT QUALITY ISSUE"},{"count":45,"reaction":"WRONG TECHNIQUE IN PRODUCT USAGE PROCESS"},{"count":42,"reaction":"VULVOVAGINAL BURNING SENSATION"},{"count":41,"reaction":"APPLICATION SITE PAIN"},{"count":41,"reaction":"DRUG INEFFECTIVE"},{"count":35,"reaction":"INCORRECT DOSE ADMINISTERED"},{"count":23,"reaction":"DEVICE ISSUE"},{"count":22,"reaction":"VULVOVAGINAL DISCOMFORT"},{"count":21,"reaction":"URINARY TRACT INFECTION"}],"_approvalHistory":[{"date":"20240216","type":"SUPPL","sponsor":"PRASCO","applicationNumber":"ANDA212313"},{"date":"20210715","type":"ORIG","sponsor":"PRASCO","applicationNumber":"ANDA212313"},{"date":"20250519","type":"SUPPL","sponsor":"PRASCO","applicationNumber":"ANDA212313"},{"date":"20240208","type":"SUPPL","sponsor":"PRASCO","applicationNumber":"ANDA212313"}],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Estrace","National Drug Code 0430-3754"],"phase":"marketed","status":"active","brandName":"Estradiol vaginal cream","genericName":"Estradiol vaginal cream","companyName":"CONRAD","companyId":"conrad","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Estradiol vaginal cream delivers the hormone estradiol directly to vaginal tissues to restore local estrogen levels and relieve menopausal vaginal symptoms. Used for Atrophic vaginitis and vaginal atrophy associated with menopause, Vaginal dryness and dyspareunia in postmenopausal women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}